Mild Traumatic Brain Injury: Finally, light at the end of the tunnel
Peter Biberthaler (Germany)

Life-Threatening Intracranial Hemorrhage, Gastrointestinal, and Trauma-Related Bleeding in Anticoagulated Patients: Optimal Management in the Emergency Department
Chair: Brian Gibler (USA)

• Intracranial Hemorrhages and Anticoagulation Reversal in the ED – Barbra Backus (Netherlands)
• Life-Threatening GI Bleeds and Anticoagulation Reversal in the ED –Richard Body (UK)
• Life-Threatening Traumatic Bleeds and Anticoagulation Reversal in the ED – Martin Möckel (Germany)

E.care ED (M4-5)

Customer experiences and New Functionalities

• Meine Erfahrungen mit E.care ED. Gregor Stolz (Germany)
• Allgemeine Erfahrungen mit E.care ED mit Fokus auf Pflege-Workflow inkl. Wertsachendokumentation. Wilfried Schnieder (Germany)
• Mobile Patient Intake. Martin Monninger & Bert Maes (Mesalvo – E.care – Belgium

The role of the emergency department in optimizing outcomes in mild to moderate Covid-19 patients
Chair: Juan Gonzalez del Castillo (Spain), Sven Schellberg (Germany)

• COVID-19: State of the art. Juan Gonzalez del Castillo (Spain), Sven Schellberg (Germany)
• Patients with suspected Covid-19 presenting to the ED today. Juan Gonzalez del Castillo (Spain)
• At home COVID-19 treatment options. Sven Schellberg (Germany)

Using rapid multiplex PCR syndromic testing to support pathogen detection for infectious diseases in the emergency department
Chair: Martí Juanola Falgarona (Qiagen)

• Overall value and benefits of syndromic testing in the emergency department. Donia Bouzid (France)
• Impact of rapid multiplex-PCR syndromic testing during covid-19 in an emergency department. Olivier Peyrony (France)

The Value of High Sensitivity Troponin at the Point of Care

• High-sensitivity troponin at the point of care: What’s the added value? Richard Body (UK)
• Paradigm shift in the care of patients with ACS. How Atellica VTLi hs-cTnI assay can revolutionize the treatment pathway at the point of care. Johannes Neumann (Germany)

Acute Dyspnea in the ED: How Biomarkers help to solve the puzzle

Chairs: Matthew Reed (UK)

• Is this infection and how severe? Martin Möckel (Germany)
• Cardiovascular dyspnea – how can I know? Evangelos Giannitsis (Germany)
• Just fatigue or more? Differential diagnosis of infection in the ED with consideration of an elderly population. Juan Gonzalez del Castillo (Spain)

Routine testing for blood-borne viruses in emergency departments: Opportunities for EM societies advancing implementation
Chair: Hartmut Stocker (Germany)

• The burden of blood-borne viruses (BBV): The need for increased routine testing. Laura Hunter (UK)
• Best practice sharing: Differing approaches in the UK and Spain. Juan González del Castillo (Spain), Laura Hunter (UK)
• Implementing routine testing: Improving health outcomes for people with undiagnosed infection. Juan González del Castillo (Spain), Rachel Hill-Tout (UK), Laura Hunter (UK)

The time is now – accelerate ACS management at the point-of-care
Chair: Barbra Backus, MD, PhD

• Future of high sensitive POC troponin in risk stratification in the prehospital setting – Barbra Backus, MD, PhD (15 minutes)
• Role of high sensitive POC troponin in risk stratification for acute coronary syndrome in the prehospital setting – Rudolf Tolsma, MSc, Ambulance IJsselland (15 minutes)
• High sensitive POC troponin in the ED: what matters? – Michael Wünning, Dr. med., Marienkrankenhaus Hamburg (15 minutes)

The vital role of the Emergency Department in the Patient’s Sepsis Pathway
Chair: Jim Connolly (UK)

Speakers: Ben Creagh-Brown (UK), Caroline Munday (UK)

Nasal high-flow therapy in the Emergency Department

Alexander Spiel (Austria), Christoph Dodt (Germany)